BRPI0317740B8 - uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1 - Google Patents
uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1Info
- Publication number
- BRPI0317740B8 BRPI0317740B8 BRPI0317740A BR0317740A BRPI0317740B8 BR PI0317740 B8 BRPI0317740 B8 BR PI0317740B8 BR PI0317740 A BRPI0317740 A BR PI0317740A BR 0317740 A BR0317740 A BR 0317740A BR PI0317740 B8 BRPI0317740 B8 BR PI0317740B8
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- difluoroprostaglandin
- keto
- dihydro
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/56—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"derivados de prostaglandinas para o tratamento de desconforto abdominal". a presente invenção refere-se a um novo uso de um abridor de canal de cloreto, especialmente um composto de prostaglandina para o tratamento de desconforto abdominal. ulteriormente descrito é um novo uso de um abridor de canal de cloreto, especialmente um composto de prostaglandina para o tratamento de distúrbios gastrointestinais funcionais.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43646302P | 2002-12-27 | 2002-12-27 | |
US43646202P | 2002-12-27 | 2002-12-27 | |
PCT/JP2003/016857 WO2004060377A1 (en) | 2002-12-27 | 2003-12-26 | Derivatives of prostaglandins for treating abdominal discomfort |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0317740A BR0317740A (pt) | 2005-11-22 |
BRPI0317740B1 BRPI0317740B1 (pt) | 2018-09-18 |
BRPI0317740B8 true BRPI0317740B8 (pt) | 2021-05-25 |
Family
ID=32717850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0317740A BRPI0317740B8 (pt) | 2002-12-27 | 2003-12-26 | uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1 |
Country Status (15)
Country | Link |
---|---|
US (3) | US7795312B2 (pt) |
EP (2) | EP2281564A3 (pt) |
JP (2) | JP4889219B2 (pt) |
KR (2) | KR101164838B1 (pt) |
CN (1) | CN1753680B (pt) |
AR (1) | AR042670A1 (pt) |
AU (1) | AU2003292556B2 (pt) |
BR (1) | BRPI0317740B8 (pt) |
CA (1) | CA2510051C (pt) |
ES (1) | ES2591252T3 (pt) |
MX (1) | MXPA05006981A (pt) |
NO (1) | NO335441B1 (pt) |
NZ (1) | NZ541110A (pt) |
TW (1) | TWI336254B (pt) |
WO (1) | WO2004060377A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI331920B (en) | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
DK1562604T3 (da) * | 2002-10-23 | 2012-04-02 | Sucampo Ag | Prostaglandinforbindelser til behandling af fedme |
JP5294559B2 (ja) * | 2003-07-03 | 2013-09-18 | スキャンポ・アーゲー | クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物 |
TWI387454B (zh) * | 2004-09-02 | 2013-03-01 | Sucampo Ag | 治療胃腸道疾病之方法及組成物 |
US20060281818A1 (en) * | 2005-03-21 | 2006-12-14 | Sucampo Ag, North Carolina State University | Method for treating mucosal disorders |
CN101180096B (zh) * | 2005-03-21 | 2015-04-22 | 苏坎波公司 | 用于治疗粘膜疾病的方法和组合物 |
JP5711442B2 (ja) * | 2005-04-12 | 2015-04-30 | スキャンポ・アーゲーSucampo AG | 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用 |
JP5427029B2 (ja) * | 2006-09-06 | 2014-02-26 | スキャンポ・アーゲー | 消化管の重炭酸分泌を促進するための方法および組成物 |
EP2114411A2 (en) * | 2007-02-27 | 2009-11-11 | Sucampo AG | Composition and method for protecting mitochondria |
US20090012165A1 (en) | 2007-07-03 | 2009-01-08 | Sucampo Ag | Pharmaceutical combination of nsaid and prostaglandin compound |
US20090030072A1 (en) * | 2007-07-03 | 2009-01-29 | Sucampo Ag | Pharmaceutical combination of opioid and prostaglandin compound |
WO2011035142A1 (en) * | 2009-09-18 | 2011-03-24 | Adolor Corporation | Use of opioid receptor antagonist for gastrointestinal tract disorders |
IT1402047B1 (it) * | 2010-10-19 | 2013-08-28 | Cross Pharma Sa | Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali |
JO3438B1 (ar) | 2011-04-13 | 2019-10-20 | Epizyme Inc | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس |
WO2013161973A1 (en) * | 2012-04-23 | 2013-10-31 | Sucampo Ag | Method for treating irritable bowel syndrome with diarrhea |
US10092572B2 (en) | 2012-10-15 | 2018-10-09 | Epizyme, Inc. | Substituted benzene compounds |
WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1581886A (en) * | 1977-05-26 | 1980-12-31 | May & Baker Ltd | Prostanol derivatives |
US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
CA1322749C (en) | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
US5221763A (en) | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
JPH0681728B2 (ja) * | 1987-10-02 | 1994-10-19 | 株式会社上野製薬応用研究所 | 下 剤 |
US5317032A (en) | 1987-10-02 | 1994-05-31 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Prostaglandin cathartic |
JP2579193B2 (ja) | 1988-07-19 | 1997-02-05 | 小野薬品工業株式会社 | 16,16−ジフルオロ−15−オキソ−15−デオキシpge誘導体 |
TW224942B (pt) | 1990-04-04 | 1994-06-11 | Adka Ueno Kk | |
EP0455448B1 (en) | 1990-05-01 | 1998-12-09 | R-Tech Ueno Ltd. | Treatment of pancreatic disease with 15-keto-prostaglandin E compounds |
CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
ES2182088T3 (es) | 1996-06-10 | 2003-03-01 | Sucampo Ag | Antagonista de la endotelina. |
US6046239A (en) * | 1997-08-05 | 2000-04-04 | American Home Products Corporation | Anthranilic acid analogs |
PT978284E (pt) * | 1997-11-28 | 2008-10-07 | Sucampo Ag | Utilização de compostos 15-ceto-prostaglandina-e como antagonistas da endotelina |
US6492417B1 (en) * | 1997-12-22 | 2002-12-10 | Alcon Manufacturing, Ltd. | 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists |
DE60010913T2 (de) | 1999-10-15 | 2005-06-09 | Sucampo Ag | Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung |
WO2001076593A2 (en) * | 2000-04-06 | 2001-10-18 | Sucampo Ag | Bile secretion promoting composition a 15-keto prostaglandin |
US6414016B1 (en) * | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
TWI302100B (en) * | 2001-05-02 | 2008-10-21 | Sucampo Ag | Composition for treating drug-induced constipation |
TWI320711B (en) * | 2001-05-18 | 2010-02-21 | Sucampo Ag | Cathartic composition |
WO2003030912A1 (en) * | 2001-08-31 | 2003-04-17 | Sucampo Ag | Prostaglandin analogs as chloride channel opener |
TWI331920B (en) * | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
US7732487B2 (en) * | 2001-11-19 | 2010-06-08 | Sucampo Ag | Method for treating a disease or condition responsive to opening of C1C-2 channel |
-
2003
- 2003-12-26 JP JP2004564537A patent/JP4889219B2/ja not_active Expired - Lifetime
- 2003-12-26 EP EP10177588A patent/EP2281564A3/en not_active Withdrawn
- 2003-12-26 KR KR1020057012162A patent/KR101164838B1/ko active Protection Beyond IP Right Term
- 2003-12-26 BR BRPI0317740A patent/BRPI0317740B8/pt active IP Right Grant
- 2003-12-26 CA CA2510051A patent/CA2510051C/en not_active Expired - Lifetime
- 2003-12-26 AU AU2003292556A patent/AU2003292556B2/en not_active Expired
- 2003-12-26 WO PCT/JP2003/016857 patent/WO2004060377A1/en active Application Filing
- 2003-12-26 TW TW092136988A patent/TWI336254B/zh not_active IP Right Cessation
- 2003-12-26 KR KR1020127006692A patent/KR20120045051A/ko not_active Application Discontinuation
- 2003-12-26 ES ES03768289.5T patent/ES2591252T3/es not_active Expired - Lifetime
- 2003-12-26 CN CN2003801099014A patent/CN1753680B/zh not_active Expired - Lifetime
- 2003-12-26 NZ NZ541110A patent/NZ541110A/en not_active IP Right Cessation
- 2003-12-26 MX MXPA05006981A patent/MXPA05006981A/es active IP Right Grant
- 2003-12-26 EP EP03768289.5A patent/EP1575596B1/en not_active Expired - Lifetime
- 2003-12-29 AR ARP030104848A patent/AR042670A1/es not_active Application Discontinuation
- 2003-12-29 US US10/745,689 patent/US7795312B2/en active Active
-
2005
- 2005-07-26 NO NO20053623A patent/NO335441B1/no not_active IP Right Cessation
-
2010
- 2010-08-02 US US12/848,597 patent/US20100298424A1/en not_active Abandoned
-
2011
- 2011-11-01 JP JP2011240314A patent/JP2012031202A/ja active Pending
-
2013
- 2013-03-18 US US13/845,353 patent/US20130217770A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20053623D0 (no) | 2005-07-26 |
NO335441B1 (no) | 2014-12-15 |
JP4889219B2 (ja) | 2012-03-07 |
EP1575596B1 (en) | 2016-06-22 |
US7795312B2 (en) | 2010-09-14 |
US20040138308A1 (en) | 2004-07-15 |
AU2003292556A1 (en) | 2004-07-29 |
NZ541110A (en) | 2008-11-28 |
EP2281564A3 (en) | 2012-09-05 |
MXPA05006981A (es) | 2005-12-14 |
CA2510051A1 (en) | 2004-07-22 |
NO20053623L (no) | 2005-09-26 |
BRPI0317740B1 (pt) | 2018-09-18 |
AR042670A1 (es) | 2005-06-29 |
KR20050086950A (ko) | 2005-08-30 |
TWI336254B (en) | 2011-01-21 |
KR20120045051A (ko) | 2012-05-08 |
CA2510051C (en) | 2016-07-05 |
KR101164838B1 (ko) | 2012-07-11 |
CN1753680A (zh) | 2006-03-29 |
US20100298424A1 (en) | 2010-11-25 |
TW200418491A (en) | 2004-10-01 |
CN1753680B (zh) | 2010-12-08 |
WO2004060377A1 (en) | 2004-07-22 |
US20130217770A1 (en) | 2013-08-22 |
EP2281564A2 (en) | 2011-02-09 |
AU2003292556B2 (en) | 2009-09-10 |
JP2006513232A (ja) | 2006-04-20 |
JP2012031202A (ja) | 2012-02-16 |
ES2591252T3 (es) | 2016-11-25 |
EP1575596A1 (en) | 2005-09-21 |
BR0317740A (pt) | 2005-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0317740B8 (pt) | uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1 | |
HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
BR0311494A (pt) | Novos indóis substituìdos | |
DE60336850D1 (en) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
TW200716520A (en) | 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | |
HUP0400206A2 (hu) | Metalloproteináz inhibitor hatású imidazolidin-dion-származékok, ezek alkalmazása gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények | |
MY138352A (en) | Benzothiazole derivatives | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
NO20032208D0 (no) | Benzodiazepinderivater som GABA A reseptormodulatorer | |
UA84271C2 (en) | Formate salt of o-desmethyl-venlafaxine | |
UA90496C2 (ru) | 18-метил-19-нор-17-прегн-4-эн-21,17-карболактоны, а также лекарственный препарат, который их содержит | |
MXPA04005886A (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6. | |
BR0211972A (pt) | Composição oftálmica | |
ATE384058T1 (de) | Thiazolderivate | |
MXPA04003087A (es) | Derivados de cromano como ligados de 5-hidroxitriptamina-6. | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
SE0101082D0 (sv) | Novel use | |
MXPA03001081A (es) | Medicamento anti-inflamatorio. | |
MXPA05006889A (es) | Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. | |
SE0200198D0 (sv) | New use | |
BR0110871A (pt) | Derivados de sulfonamida | |
CR7039A (es) | Modificacion cristalina de un depsipeptido ciclico con actividad mejorada | |
BR0110874A (pt) | Derivados de sulfonamida | |
AR106393A2 (es) | Uso del abridor del canal de cloruro para preparar un compuesto farmacéutico para tratar el malestar abdominal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/09/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/12/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |